Aspire Biopharma Holdings, Inc. (ASBP)
NASDAQ: ASBP · Real-Time Price · USD
0.205
-0.004 (-2.01%)
Apr 29, 2026, 10:22 AM EDT - Market open
Aspire Biopharma Holdings Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Market Capitalization | 1 | 14 | 89 | 98 | 370 |
| Market Cap Growth | -99.99% | -84.13% | -8.80% | -73.55% | - |
| Enterprise Value | 5 | 21 | 90 | - | - |
| Last Close Price | 0.21 | 5.28 | 460.00 | 435.60 | 412.00 |
| PS Ratio | 169.06 | 2285.75 | - | - | - |
| PB Ratio | - | -2.22 | -57.98 | -200.70 | -2874.10 |
| P/OCF Ratio | - | - | - | 8792.58 | - |
| EV/Sales Ratio | 841.65 | 3362.26 | - | - | - |
| Debt / Equity Ratio | -0.81 | -0.81 | -0.82 | -0.74 | -0.22 |
| Net Debt / Equity Ratio | -0.65 | -0.65 | -0.82 | -0.72 | -0.22 |
| Asset Turnover | 0.01 | 0.01 | - | - | - |
| Quick Ratio | 0.13 | 0.13 | 0.00 | 0.02 | 0 |
| Current Ratio | 0.17 | 0.17 | 0.09 | 0.09 | 0.15 |
| Return on Assets (ROA) | -446.87% | -446.87% | -779.55% | -652.34% | - |
| Return on Capital Employed (ROCE) | 83.10% | 83.10% | 78.60% | 73.50% | 463.20% |
| Earnings Yield | -2334.77% | -172.69% | -1.47% | -0.37% | -0.16% |
| Buyback Yield / Dilution | -116.69% | -116.69% | 99.84% | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.